Genmab AS (GMAB)
NASDAQ
News
Market Data
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current GMAB market cap is 12.77B. The company's latest EPS is DKK 11.8512 and P/E is 16.06.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | |
| Total Revenue | 4.68B | 4.14B | 5.4B | 5.54B | 6.44B |
| Operating Income | -693M | 801M | 1.64B | 426M | -381M |
| Net Income | 640M | 1.33B | 1.41B | 1.27B | 3.85B |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | |
| Total Revenue | 10.11B | 8.48B | 14.6B | 16.47B | 21.53B |
| Operating Income | 6.31B | 3.02B | 6.36B | 5.32B | 6.7B |
| Net Income | 4.76B | 3.01B | 5.52B | 4.35B | 7.84B |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | |
| Total Assets | 35.29B | 36.68B | 38.62B | 39.66B | 45.81B |
| Total Liabilities | 3.68B | 4.18B | 7.65B | 7.74B | 9.11B |
| Total Equity | 31.61B | 32.5B | 30.97B | 31.92B | 36.7B |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | |
| Total Assets | 21.14B | 24.63B | 30.28B | 35.29B | 45.81B |
| Total Liabilities | 2.02B | 2.43B | 2.84B | 3.68B | 9.11B |
| Total Equity | 19.12B | 22.2B | 27.44B | 31.61B | 36.7B |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | |
| Operating | 7.38B | 1.51B | 3.03B | 5.06B | 7.77B |
| Investing | -1.28B | -1.44B | -10.21B | -9.99B | -9.91B |
| Financing | -606M | -595M | -3.65B | -3.92B | -3.92B |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | |
| Operating | 6.43B | 2.23B | 3.91B | 7.38B | 7.77B |
| Investing | -2.35B | -961M | -2.76B | -1.28B | -9.91B |
| Financing | 71M | -420M | -789M | -606M | -3.92B |
| Market Cap | 12.77B |
| Price to Earnings Ratio | 16.06 |
| Price to Sales Ratio | 5.85 |
| Price to Cash Ratio | 12.78 |
| Price to Book Ratio | 3.43 |
| Dividend Yield | - |
| Shares Outstanding | 661.87M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.08 (0.41%) |
| Company Name | Genmab AS |
| Address |
kalvebod brygge 43 copenhagen 1260 |
| Website | https://www.genmab.com |
| Industry | biogenetic (human) (H4) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
